CD4 and infection: In most vaccine trials conducted in treated patients cART therapy was interrupted to assess the potency of the immunological control of infection provided by vaccination, while they were not aimed at evaluating the immunological recovery, with the exclusion of CD4+ T cell counts, which, however, did not appear to go beyond the restoration provided by cART alone [9, 79].